Open AccessEnhancing adherence, subjective well-being and quality of life in patients with schizophrenia: which role for long-acting risperidone?
Author(s) -
Cinzia Niolu,
Emanuela Bianciardi,
Giorgio Di Lorenzo,
Claudia Marchetta,
Ylenia Barone,
Nicoletta Sterbini,
Michele Ribolsi,
Giorgio Reggiardo,
Alberto Siracusano
Publication year - 2015
Publication title -
therapeutic advances in psychopharmacology
Language(s) - English
Resource type - Journals
eISSN - 2045-1261
pISSN - 2045-1253
DOI - 10.1177/2045125315596897
Subject(s) - risperidone , quality of life (healthcare) , medicine , schizophrenia (object oriented programming) , analysis of variance , observational study , repeated measures design , psychiatry , statistics , mathematics , nursing
This study evaluated adherence to treatment, quality of life and subjective well-being in patients with psychosis treated with long-acting injectable risperidone. Subjects enrolled were part of a larger study where patients were observed in an adherence to treatment program of the University of Rome Tor Vergata.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom